Local thrombolytics via balloon-assisted intra-arterial infusion as rescue therapy for thromboembolism during endovascular coil embolisation.


Journal

BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291

Informations de publication

Date de publication:
24 Oct 2023
Historique:
medline: 27 10 2023
pubmed: 26 10 2023
entrez: 25 10 2023
Statut: epublish

Résumé

Thromboembolism is the most frequent complication of coil embolisation for intracranial aneurysm. Complications of thromboembolism can lead to stroke and have a serious impact on sequelae and mortality, necessitating appropriate rescue therapy. Here, we succeeded in recanalisation of an occluded stent by balloon-assisted local infusion of a thrombolytic agent following stent-assisted coil embolisation of an unruptured posterior communicating artery aneurysm. This method involves inflating a microballoon just distal to the occluded vessel and then administering a thrombolytic agent through a microcatheter. This technique may increase the rate of vessel reopening by maximising the local drug concentration. This method can be applied to any type of thrombolytic agent and helps reduce the dose of systemic drugs, which might decrease the incidence of haemorrhagic complications. Balloon-assisted intra-arterial thrombolytic infusion for an occluded vessel during endovascular coil embolisation could offer an alternative rescue therapy when conventional thrombolytic agent administration fails to improve thromboembolism.

Identifiants

pubmed: 37879706
pii: 16/10/e256134
doi: 10.1136/bcr-2023-256134
pmc: PMC10603458
pii:
doi:

Substances chimiques

Fibrinolytic Agents 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© BMJ Publishing Group Limited 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

AJNR Am J Neuroradiol. 2015 Jan;36(1):121-5
pubmed: 25082819
J Neuroendovasc Ther. 2021;15(11):707-711
pubmed: 37502270
J Neuroradiol. 2019 Feb;46(1):15-24
pubmed: 29733918
AJNR Am J Neuroradiol. 2006 Aug;27(7):1498-501
pubmed: 16908567
J Neurosurg. 1997 Mar;86(3):475-82
pubmed: 9046305

Auteurs

Michiyasu Fuga (M)

Department of Neurosurgery, Jikei University School of Medicine Kashiwa Hospital, Kashiwa‑shi, Chiba, Japan fugamichiyasu@icloud.com.

Toshihide Tanaka (T)

Department of Neurosurgery, Jikei University School of Medicine Kashiwa Hospital, Kashiwa‑shi, Chiba, Japan.
Department of Neurosurgery, Jikei University School of Medicine, Minato-ku, Tokyo, Japan.

Akihiko Teshigawara (A)

Department of Neurosurgery, Jikei University School of Medicine Kashiwa Hospital, Kashiwa‑shi, Chiba, Japan.

Yuichi Murayama (Y)

Department of Neurosurgery, Jikei University School of Medicine, Minato-ku, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH